SELLAS Life Sciences Group Inc's (NYSE:SLS) short interest as a percent of float has risen 21.68% since its last report. According to exchange reported data, there are now 40.47 million shares sold short, which is 28.62% of all regular shares that are available for trading. Based on its trading v... Read more
Benzinga - Dec 25
Wave Life Sciences Ltd. (NASDAQ:WVE) stock rose Tuesday on continued optimism after the company announced data from the lowest therapeutic cohort of the ongoing INLIGHT trial of WVE-007 for weight loss.On Monday, the company said that a single 240 mg dose of WVE-007 led to an improvement in body ... Read more
Benzinga - Dec 09
Taylor Gray has tried to control his glioblastoma – a malignant brain tumor – with surgery, radiation and chemotherapy. After struggling to improve his quality of life with the treatments, his radiation oncologist introduced him to Optune Gio, a wearable, portable medical device created by Novocu... Read more
Concord Monitor - Nov 14
TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) and Cresco Labs (OTCMKTS:CRLBF – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, ear... Read more
Americanbankingnews - Nov 12
Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) fell 6.7% during mid-day trading on Monday . The stock traded as low as $6.62 and last traded at $6.80. 982,503 shares were traded during trading, a decline of 13% from the average session volume of 1,135,440 shares. The stock h... Read more
Watch List News - Nov 10
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation ... Read more
Openpr.com - Nov 05
Scotland’s life sciences sector is at a crossroads, facing significant challenges but also unprecedented opportunities. Read more
The Scotsman - Oct 30
The New Birmingham Health Innovation Campus research hub was opened earlier this year Read more
Birmingham Live - Oct 22
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients” Read more
Globenewswire_fr - Sep 30
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates. Read more
Medical News - Sep 15
